Lauren Ann Dalvin MD
Ocular Oncology
Associate Professor of Ophthalmology, Mayo Medical School
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Dalvin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lauren A. Dalvin is an ocular oncologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. She completed her residency training at Mayo Clinic and a 2-year ocular oncology fellowship at Wills Eye Hospital. She specializes in ocular oncology.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Ocular Oncology/Ophthalmic Pathology, 2017 - 2019
Mayo Clinic College of Medicine and Science (Rochester)Residency, Ophthalmology, 2014 - 2017
Northeast Ohio Medical UniversityClass of 2013
Certifications & Licensure
MN State Medical License 2014 - 2025
PA State Medical License 2017 - 2022
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Assessment of choroidal melanoma and nevus lesions using ultrasound vibro-elastography and parametric imaging approach.Ngoc Thang Bui, Lauren A Dalvin, Xiaoming Zhang
Ultrasonics. 2025-11-01 - Clinical characteristics and outcomes of primary orbital lymphoma.Kenny Y Wang, B Michelle Kim, Caroline Y Yu, Grant M Welk, Robert A Churchill
European Journal of Ophthalmology. 2025-09-01 - Ocular toxicities associated with MEK/BRAF inhibitors: assessing the accuracy and completeness of large language models.Nila Kirupaharan, Camellia Edalat, Lauren A Dalvin, Kapil Mishra, Rayna Marshall
Eye. 2025-08-29
Authored Content
- Fundus Imaging Reveals Lesion Features That May Help Identify Mosaic RASopathyApril 2024
- Recognizing Pseudonecrotic Retinal Lesions May Help Diagnose Vitreoretinal LymphomaFebruary 2024
- Tebentafusp May Offer a Survival Benefit for Patients with Uveal MelanomaMay 2023
- Prognostic Scoring System May Aid in Assessing Treatment Risk for Uveal MelanomaMarch 2023
- Overall Survival Benefit with Tebentafusp in Metastatic Uveal MelanomaApril 2022
- Join now to see all
Press Mentions
Gerstner Scholars Program in AI TranslationJune 19th, 2025- Surveillance Screening Protocols for Low-Risk Uveal Melanoma May Need RevisionMay 13th, 2025
- 3D Models of Uveal Melanoma Offer Hope for Improved TreatmentsJanuary 30th, 2025
- Join now to see all
Grant Support
- Characterization and treatment of a novel model of radiation optic neuropathy using the tree shrewMAYO CLINIC ROCHESTER2024–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
